1. Home
  2. FEMY vs SYNX Comparison

FEMY vs SYNX Comparison

Compare FEMY & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • SYNX
  • Stock Information
  • Founded
  • FEMY 2004
  • SYNX 2005
  • Country
  • FEMY United States
  • SYNX Israel
  • Employees
  • FEMY N/A
  • SYNX N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • SYNX
  • Sector
  • FEMY Health Care
  • SYNX
  • Exchange
  • FEMY Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • FEMY 12.5M
  • SYNX 11.3M
  • IPO Year
  • FEMY 2021
  • SYNX 2024
  • Fundamental
  • Price
  • FEMY $0.36
  • SYNX $1.58
  • Analyst Decision
  • FEMY Strong Buy
  • SYNX
  • Analyst Count
  • FEMY 3
  • SYNX 0
  • Target Price
  • FEMY $7.33
  • SYNX N/A
  • AVG Volume (30 Days)
  • FEMY 2.9M
  • SYNX 145.2K
  • Earning Date
  • FEMY 11-11-2025
  • SYNX 10-02-2025
  • Dividend Yield
  • FEMY N/A
  • SYNX N/A
  • EPS Growth
  • FEMY N/A
  • SYNX N/A
  • EPS
  • FEMY N/A
  • SYNX N/A
  • Revenue
  • FEMY $1,887,016.00
  • SYNX $9,094,000.00
  • Revenue This Year
  • FEMY $103.55
  • SYNX $32.35
  • Revenue Next Year
  • FEMY $148.13
  • SYNX N/A
  • P/E Ratio
  • FEMY N/A
  • SYNX N/A
  • Revenue Growth
  • FEMY 98.61
  • SYNX 19.14
  • 52 Week Low
  • FEMY $0.31
  • SYNX $1.41
  • 52 Week High
  • FEMY $1.80
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 28.31
  • SYNX 45.13
  • Support Level
  • FEMY $0.35
  • SYNX $1.54
  • Resistance Level
  • FEMY $0.40
  • SYNX $1.76
  • Average True Range (ATR)
  • FEMY 0.04
  • SYNX 0.17
  • MACD
  • FEMY 0.01
  • SYNX 0.00
  • Stochastic Oscillator
  • FEMY 5.20
  • SYNX 22.97

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: